58MEDIUM

OPT

OPTHEA FPO [OPT]
Healthcare · ASX Small Cap
$0.6000 +0.0%

Updated 2026-03-01 · Scores refresh every scan

⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.

Score Breakdown

Technical56
Catalyst50
Sentiment48
Fundamental52
Momentum46
Risk Gate25

Active Signals

Bullish Signals

  • Price at lower Bollinger Band (oversold)
  • Testing resistance level
  • Critical cash runway (1.2 quarters)
  • 4C filed 2026-01-29
  • Very high P/S ratio (5621.8x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (2% of range)
  • CANSLIM I: Institutional ownership (31%)
  • Low sentiment confidence (10% sources)
  • Sentiment based on search trends only
  • Altman Z-Score in distress zone (1.42 < 1.81)
  • Liquidity risk: 20 zero-volume days in last 20
  • ASX200 bullish (+1.9% 5d)
  • RBA cutting (+2pts)
  • Trial readout: PHASE2 (est. 2019-05-14)

Risk Signals

  • Below 200-day MA (long-term downtrend)
  • Piotroski F-Score weak (2/9)
  • Declining Google search interest
  • Neutral/mixed sentiment

Recent Catalysts

LOW Quarterly Activities/Appendix 4C Cash Flow Report
NONE Long Term Suspended Entities
NONE Notification of cessation of securities - OPT

Recent ASX Announcements

2026-01-29 Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE
2026-01-22 Long Term Suspended Entities PRICE SENSITIVE
2026-01-15 Notification of cessation of securities - OPT

Key Metrics

$820.8M
Market Cap
N/A
Avg Volume
N/A
Vol Ratio
$0.59 — $0.99
52-Week Range
2.9%
Short Interest
1 qtrs
Cash Runway
N/A
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 57%
LLeader vs LaggardlaggardRS: 0
IInstitutional SponsorshippassInst: 31%
MMarket DirectionpassBullish

Sector: Healthcare

Ranked #2 of 14 · Sector avg: 54

View all Healthcare signals →
Related Tickers
ACL 60PTX 57AVH 56TLX 55NEU 55

Sign up free to unlock OPT analysis

Score breakdowns, signals, catalysts, and full analysis for 2,200+ ASX small caps. All features free during early access.

No credit card required. Unsubscribe anytime.
Already have access? Log in